RxDoctor Payments Data

Kathryn Klayum

Obstetrics & Gynecology · Lincoln, NENPI 1295129203

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,747 of the $2,706 with a category attached, or 64.5%. 24 manufacturers reported payments, led by Intuitive Surgical at 41.8% of the total. Reporting peaked in 2024 at $1,550 and has fallen 86.9% since, to $202 in 2025.

$2,706in general payments, 2019–2025

Across 83 payments — averaging $32.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$1K
  • AbbVie$541
  • Astellas Pharma US Inc$201
  • Exeltis, USA Inc.$107
  • Biogen$99
  • Organon$98
  • plus $528 from 18 others

What the payments were for

  • Travel & lodging$94335%
  • Food & beverage$1,74765%
  • Education$161%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,706 in reported general payments places this provider in the 80th percentile of 242 obstetrics & gynecology providers in Nebraska.

See all obstetrics & gynecology providers in Nebraska

Medicare billing

Part B allowed, 2024
$5,484
Medicare patients
25
Services billed
63

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol12$630

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Lincoln

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →